Biotech · Private company
Olympic Ophthalmics, Inc.
Track this companyFree. Adds Olympic Ophthalmics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- iLIDS100Phase 1 · MicroBlepharoexfoliation, NuLids, iTEAR100, iLIDS100, Blepharitis, Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- iTEAR100Dry Eye SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- iTEAR100Visual Display Users With Previously Undiagnosed Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- iTEAR100 treatmentDry EyeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and NeurostimulationPHASE1 · UNKNOWN · started Jan 19, 2024ClinicalTrials.gov NCT06235450 · fetched Nov 12, 2026
- Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye PatientsPHASE4 · UNKNOWN · started Mar 1, 2022ClinicalTrials.gov NCT05304637 · fetched Nov 12, 2026
- A Usability Study of External Neuromodulation With iTEAR100 Generation 2PHASE4 · UNKNOWN · started Mar 1, 2022ClinicalTrials.gov NCT05304650 · fetched Nov 12, 2026
- Study of External Neuromodulation to Improve Signs and Symptoms of Dry Eye in Visual Display Terminal UsersNA · UNKNOWN · started Feb 17, 2021ClinicalTrials.gov NCT04763018 · fetched Nov 12, 2026